...
首页> 外文期刊>Polyhedron: The International Journal for Inorganic and Organometallic Chemistry >Ruthenium(III) complexes with modified nucleobases: N-6-substituted adenines
【24h】

Ruthenium(III) complexes with modified nucleobases: N-6-substituted adenines

机译:具有修饰核碱基的钌(III)配合物:N-6取代的腺嘌呤

获取原文
获取原文并翻译 | 示例
           

摘要

New chlorido-dimethylsulfoxide-ruthenium(III) complexes with different N-6-substituted adenines have been prepared and characterized. Three ruthenium complexes have been structurally characterized by X-ray diffraction crystallography: [(RuCl4)-Cl-III(DMSO)[H-(N-6-pentyladenine)]] (1), [(RuCl4)-Cl-III(DMSO)[H-(N-6-hexyladenine)]] (2) and [(RuCl4)-Cl-III(DMSO)[H-(N-6,N-6-dibutyladenine)]] (3). In all cases ruthenium ion show octahedral geometry coordinated to four chlorido ligands and one S coordinated sulfoxide (DMSO). The coordination sphere is completed by an adenine moiety coordinated to Ru(III) via N(9) and protonated at N(3). Other similar complexes have been obtained with N-6-propyladenine, [(RuCl4)-Cl-III(DMSO)[H-(N-6-propyladenine)]] - 0.5EtOH (4) and N-6-benzylaminopurine (BAP) [(RuCl4)-Cl-III(DMSO)[H-(BAP)]]center dot 0.5H(2)O (5) which have been spectroscopically characterized. Otherwise, in. different reaction conditions, we have obtained an out sphere complex of Ru(II), [H-(BAP)][(RuCl3)-Cl-II(DMSO)(3)] (6), with identical complex unit than the structurally solved [H-(creat)][(RuCl3)-Cl-II(DMSO)(3)] (7) which was included for comparison purposes. Preliminary electrophoretic mobility and atomic force microscopy (AFM) studies of the interaction between Ru(III) compounds and plasmidic DNA pBR322 have been performed. These results show different morphological changes in plasmidic DNA forms. (C) 2008 Elsevier Ltd. All rights reserved.
机译:已经制备并表征了具有不同的N-6-取代的腺嘌呤的新的氯代-二甲基亚砜-钌(III)配合物。三种钌配合物已通过X射线衍射晶体学进行了结构表征:[[(RuCl4)-Cl-III(DMSO)[H-(N-6-pentyladenine)]](1),[(RuCl4)-Cl-III( DMSO)[H-(N-6-己基腺嘌呤)]](2)和[(RuCl4)-Cl-III(DMSO)[H-(N-6,N-6-二丁基腺嘌呤)]](3)。在所有情况下,钌离子的八面体几何形状均与四个氯配体和一个S配位亚砜(DMSO)配位。配位球由通过N(9)与Ru(III)配位并在N(3)质子化的腺嘌呤部分完成。已使用N-6-丙基腺嘌呤,[((RuCl4)-Cl-III(DMSO)[H-(N-6-丙基腺嘌呤)]]-0.5EtOH(4)和N-6-苄基氨基嘌呤(BAP)获得了其他类似的络合物)[(RuCl4)-Cl-III(DMSO)[H-(BAP)]]中心点0.5H(2)O(5)已通过光谱表征。否则,在不同的反应条件下,我们获得了Ru(II),[H-(BAP)] [(RuCl3)-Cl-II(DMSO)(3)](6)的球形配合物比结构上解析的[H-(创建)] [(RuCl3)-Cl-II(DMSO)(3)](7)更高。 Ru(III)化合物与质粒DNA pBR322之间相互作用的初步电泳迁移率和原子力显微镜(AFM)研究已经进行。这些结果显示质粒DNA形式的不同形态变化。 (C)2008 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号